Roberta Karpathy, B Sc, Ph.D., joined ImmVirX in 2020, following 15 years as Director of Operations and Clinical Supply with Viralytics. She has over twenty years of experience in viral vaccine R&D, quality assurance and commercial production and, more recently, clinical trial management.

She is playing a key role in implementing and preparing for the manufacture, release testing and subsequent human clinical trials of oncolytic immunotherapies. This includes protocol design, site initiations and clinical laboratory support to progress the company’s immunotherapeutic program. Additionally, she supports Regulatory Affairs in preparation of key documents required for global human clinical studies such as submitted to the FDA, EMA and TGA.